Trulieve Cannabis (TRLV) reported Friday Q2 adjusted earnings of $0.11 per diluted share, swinging from a $0.04 loss a year earlier.
Analysts polled by FactSet expected $0.03.
Revenue for the quarter ended June 30 was $271 million, down from $302.1 million a year earlier.
Analysts polled by FactSet expected $268.5 million.